APRILE, LARA
 Distribuzione geografica
Continente #
NA - Nord America 1.053
EU - Europa 974
AS - Asia 159
OC - Oceania 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.193
Nazione #
US - Stati Uniti d'America 1.050
GB - Regno Unito 354
IE - Irlanda 198
CN - Cina 130
UA - Ucraina 98
SE - Svezia 96
IT - Italia 72
DE - Germania 65
FR - Francia 46
FI - Finlandia 22
SG - Singapore 10
VN - Vietnam 8
RU - Federazione Russa 6
BE - Belgio 4
AU - Australia 3
CZ - Repubblica Ceca 3
IN - India 3
NL - Olanda 3
CA - Canada 2
EC - Ecuador 2
IR - Iran 2
PT - Portogallo 2
SM - San Marino 2
TR - Turchia 2
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
KZ - Kazakistan 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
Totale 2.193
Città #
Southend 335
Dublin 197
Fairfield 160
Chandler 111
Woodbridge 102
Jacksonville 79
Ashburn 69
Wilmington 69
Ann Arbor 61
Houston 53
Seattle 49
Cambridge 45
Nanjing 32
Princeton 32
Beijing 31
Siena 20
Boardman 13
New York 12
Nanchang 10
Shanghai 10
Dong Ket 8
Helsinki 7
San Mateo 7
Hebei 6
San Diego 6
Singapore 6
Tianjin 6
Shenyang 5
Brussels 4
Cagliari 4
Florence 4
London 4
Moscow 4
Norwalk 4
Poggibonsi 4
Taizhou 4
Zhengzhou 4
Atlanta 3
Brno 3
Changsha 3
Hangzhou 3
San Francisco 3
Arezzo 2
Arienzo 2
Bethesda 2
Boston 2
Brescia 2
Campi Bisenzio 2
Castiglion Fiorentino 2
Dallas 2
Düsseldorf 2
Falkenstein 2
Guangzhou 2
Haikou 2
Hyderabad 2
Izmir 2
Jiaxing 2
Kansas City 2
Kunming 2
Leawood 2
Lisbon 2
Menlo Park 2
Ningbo 2
Paliano 2
Pisa 2
Quito 2
Redwood City 2
Sacramento 2
Serravalle 2
Vienna 2
Adelaide 1
Akron 1
Almaty 1
Almere Stad 1
Canberra 1
Catania 1
Cheboksary 1
Chengdu 1
Chicago 1
Chiswick 1
Copenhagen 1
Dearborn 1
Fremont 1
Fuzhou 1
Hamilton 1
Jinan 1
Kilburn 1
Lanzhou 1
Malang 1
Markham 1
Melbourne 1
Mexico City 1
Munich 1
Málaga 1
Paderno Dugnano 1
Padova 1
Phoenix 1
Pune 1
Rome 1
Salerno 1
Totale 1.678
Nome #
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 190
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 190
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 147
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 141
Peptide vaccines for hematological malignancies: a missed promise? 133
null 130
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. 129
Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients. 125
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 125
Flow-cytometry evaluation of residual Leukemia Stem Cells in Chronic Myeloid Leukemia patients: feasibility and clinical application. 123
FLT3 inhibitors in the management of acute myeloid leukemia 118
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 115
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial 112
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination 109
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion 99
Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy 93
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 72
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlation 52
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 18
Totale 2.221
Categoria #
all - tutte 6.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020512 58 18 28 75 37 47 36 76 55 43 11 28
2020/2021324 15 38 11 32 25 27 18 42 32 22 23 39
2021/2022229 24 16 12 27 14 11 11 7 10 27 23 47
2022/2023359 19 30 48 52 31 79 1 33 35 5 17 9
2023/2024275 12 7 27 4 5 75 109 11 0 5 2 18
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 2.221